Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zogenix Inc (NASDAQ:ZGNX)

10.20
Delayed Data
As of Feb 17
 -0.25 / -2.39%
Today’s Change
7.33
Today|||52-Week Range
13.70
-16.05%
Year-to-Date
No recent news for Zogenix Inc.

Today’s Trading

Previous close10.45
Today’s open10.45
Day’s range10.15 - 10.55
Volume216,817
Average volume (3 months)258,326
Market cap$252.9M
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-578.65%
Earnings growth (this year)-323.36%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-31.70%
P/E ratioNM
Price/Sales11.42
Price/Book1.38

Competitors

 Today’s
change
Today’s
% change
MNKDMannKind Corp-0.01-1.96%
TGTXTG Therapeutics Inc-0.05-1.06%
TTPHTetraphase Pharmaceu...+0.09+1.69%
IDRAIdera Pharmaceutical...+0.06+3.57%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.81
Annual revenue (last year)$27.7M
Annual profit (last year)-$49.3M
Net profit margin-150.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Stephen J. Farr
CFO, Secretary, Treasurer &
Executive VP
Michael P. Smith
Corporate headquarters
Emeryville, California

Forecasts


Search for Jobs